{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:03:30Z","timestamp":1785193410068,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.cpet.2023.02.002","type":"journal-article","created":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T15:49:25Z","timestamp":1680536965000},"page":"315-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer"],"prefix":"10.1016","volume":"18","author":[{"given":"Manuel","family":"R\u00f6hrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cpet.2023.02.002_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and neck cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.cpet.2023.02.002_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.oraloncology.2015.04.005","article-title":"Adenoid cystic carcinoma of the head and neck--An update","volume":"51","author":"Coca-Pelaz","year":"2015","journal-title":"Oral Oncol"},{"issue":"7","key":"10.1016\/j.cpet.2023.02.002_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11864-017-0484-y","article-title":"Overview of the 8th Edition TNM Classification for head and neck cancer","volume":"18","author":"Huang","year":"2017","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.cpet.2023.02.002_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semnuclmed.2020.07.005","article-title":"Imaging of head and neck cancer with CT, MRI, and US","volume":"51","author":"Junn","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2023.02.002_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.semnuclmed.2020.07.008","article-title":"Role of non-FDG-PET\/CT in head and neck cancer","volume":"51","author":"Marcus","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"7","key":"10.1016\/j.cpet.2023.02.002_bib6","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2967\/jnumed.121.262426","article-title":"Correlation of (68)Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational Exploratory study","volume":"63","author":"Mona","year":"2022","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cpet.2023.02.002_bib7","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.radonc.2021.04.016","article-title":"68)Ga-FAPI-PET\/CT improves diagnostic staging and radiotherapy planning of adenoid cystic carcinomas - imaging analysis and histological validation","volume":"160","author":"Rohrich","year":"2021","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.cpet.2023.02.002_bib8","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2967\/jnumed.118.215913","article-title":"68)Ga-FAPI PET\/CT: biodistribution and preliminary dosimetry Estimate of 2 DOTA-Containing FAP-targeting agents in patients with various cancers","volume":"60","author":"Giesel","year":"2019","journal-title":"J\u00a0Nucl Med"},{"issue":"10","key":"10.1016\/j.cpet.2023.02.002_bib9","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00259-021-05266-7","article-title":"Equivalent tumor detection for early and late FAPI-46 PET acquisition","volume":"48","author":"Ferdinandus","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2023.02.002_bib10","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.122.264069","article-title":"Repetitive early FAPI-PET acquisition comparing FAPI-02, FAPI-46 and FAPI-74: methodological and diagnostic implications for malignant, inflammatory and degenerative lesions","author":"Glatting","year":"2022","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.cpet.2023.02.002_bib11","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1007\/s00259-021-05422-z","article-title":"Targeting fibroblast activation protein in newly diagnosed squamous cell carcinoma of the oral cavity - initial experience and comparison to [(18)F]FDG PET\/CT and MRI","volume":"48","author":"Linz","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"9","key":"10.1016\/j.cpet.2023.02.002_bib12","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1007\/s00330-022-08686-7","article-title":"Accurate preoperative staging with [(68)Ga]Ga-FAPI PET\/CT for patients with oral squamous cell carcinoma: a comparison to 2-[(18)F]FDG PET\/CT","volume":"32","author":"Chen","year":"2022","journal-title":"Eur Radiol"},{"issue":"11","key":"10.1016\/j.cpet.2023.02.002_bib13","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1007\/s00259-021-05336-w","article-title":"Clinical utility of [(68)Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography\/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma","volume":"48","author":"Zhao","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.cpet.2023.02.002_bib14","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1007\/s00259-021-05255-w","article-title":"A\u00a0head-to-head comparison of (68)Ga-DOTA-FAPI-04 and (18)F-FDG PET\/MR in patients with nasopharyngeal carcinoma: a prospective study","volume":"48","author":"Qin","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.cpet.2023.02.002_bib15","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s12149-022-01742-8","article-title":"68)Ga-DOTA-FAPI-04 PET\/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients","volume":"36","author":"Chen","year":"2022","journal-title":"Ann Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2023.02.002_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1148\/radiol.212430","article-title":"68)Ga fibroblast activation protein inhibitor PET\/CT in the detection of metastatic thyroid cancer: comparison with (18)F-FDG PET\/CT","volume":"304","author":"Fu","year":"2022","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.cpet.2023.02.002_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s12020-021-02800-3","article-title":"Liver metastases from medullary thyroid carcinoma detected on (68)Ga-FAPI-04 PET\/CT","volume":"74","author":"Kuyumcu","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.cpet.2023.02.002_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2967\/jnumed.121.262790","article-title":"The added value of (68)Ga-FAPI PET\/CT in patients with head and neck cancer of unknown primary with (18)F-FDG-Negative findings","volume":"63","author":"Gu","year":"2022","journal-title":"J\u00a0Nucl Med"},{"issue":"17","key":"10.1016\/j.cpet.2023.02.002_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174253","article-title":"FAP-specific signalling is an independent diagnostic approach in ACC and not a surrogate marker of MRI sequences","volume":"14","author":"Liew","year":"2022","journal-title":"Cancers"},{"issue":"12","key":"10.1016\/j.cpet.2023.02.002_bib20","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1007\/s00259-020-04859-y","article-title":"Fibroblast activation protein inhibitor (FAPI) PET for diagnostics and advanced targeted radiotherapy in head and neck cancers","volume":"47","author":"Syed","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2023.02.002_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s11307-022-01749-7","article-title":"Head-to-Head comparison of [(68) Ga]Ga-FAPI-46-PET\/CT and [(18)F]F-FDG-PET\/CT for radiotherapy planning in head and neck cancer","author":"Wegen","year":"2022","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"10.1016\/j.cpet.2023.02.002_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.2967\/jnumed.121.262808","article-title":"Pitfalls and Common findings in (68)Ga-FAPI PET: a pictorial analysis","volume":"63","author":"Kessler","year":"2022","journal-title":"J\u00a0Nucl Med"},{"issue":"2","key":"10.1016\/j.cpet.2023.02.002_bib23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2967\/jnumed.120.244723","article-title":"Fibroblast activation protein-targeted PET\/CT with (68)Ga-FAPI for imaging IgG4-related disease: comparison to (18)F-FDG PET\/CT","volume":"62","author":"Luo","year":"2021","journal-title":"J\u00a0Nucl Med"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859823000159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859823000159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:11:39Z","timestamp":1761563499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859823000159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S1556859823000159"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2023.02.002","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2023.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}